Evaluation of standard and high-dose contrast-enhanced breath-hold liver magnetic resonance for visualization of metastatic disease in an animal model

Investigative Radiology

Volumn 33, Issue 5, 1998, Pages 263-267

  Runge, Val M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Gadolinium; Liver; Magnetic resonance imaging; Neoplasms

Indexed keywords

GADOLINIUM;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREATH HOLDING; CLINICAL PRACTICE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG MEGADOSE; LIVER METASTASIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT;

EID: 0031903286     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199805000-00002     Document Type: Article

References (12)

1. Paley MR, Ros PR. MR imaging of the liver: A practical approach. Magn Reson Imaging Clin North Am 1997;5:415-429.
2. Giovagnoni A, Paci E. Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg). Magn Reson Imaging Clin North Am 1996;4:61-72.
3. Spinazzi A, Pirovano G, Ratcliffe G, Pezzoli C, Rosati G. Multicenter testing of gadobenate dimeglumine in magnetic resonance imaging of focal liver disease. Acad Radiol 1996;3(suppl 2):S415-S416.
4. Reimer P, Rummeny EJ, Shamsi K, et al. Phase II clinical evaluation of Gd-EOB-DTPA: Dose, safety aspects, and pulse sequence. Radiology 1996;199:177-183.
5. Van Beers BE, Gallez B, Pringot J. Contrast-enhanced MR imaging of the liver. Radiology 1997;203:297-306.
6. Vogl TJ, Hammerstingl R, Schwarz W, et al. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 1996;198:881-887.
7. Schwartz LH, Seltzer SE, Tempany CM, et al. Superparamagnetic iron oxide hepatic MR imaging: Efficacy and safety using conventional and fast spin-echo pulse sequences. J Magn Reson Imaging 1995;5:566-570.
8. Mitchell DG, Saini S, Weinreb J, et al. Hepatic metastases and cavernous hemangiomas: Distinction with standard and triple dose gadoteridol enhanced MR imaging. Radiology 1994;193:49-57.
9. Hamm B, Wolf KJ, Felix R. Conventional and rapid MR imaging of the liver with Gd DTPA. Radiology 1987;164:313-320.
10. Edelman RR, Siegel JB, Singer A, et al. Dynamic MR imaging of the liver with Gd DTPA: Initial clinical results. AJR Am J Roentgenol 1989;153:1213-1219.
11. Soyer P, de Givry SC, Gueye C, Lenormand S, Somveille E, Scherrer A. Detection of focal hepatic lesions with MR imaging: Prospective comparison of T2-weighted fast spin-echo with and without fat suppression, T2-weighted breath-hold fast spin-echo, and gadolinium chelate-enhanced 3D gradient-recalled imaging. AJR Am J Roentgenol 1996;166:1115-1121.
12. Peterson MS, Baron RL, Murakami T. Hepatic malignancies: Usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging. Radiology 1996;201:337-345.